![John Henderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Henderson
Presidente presso
CYTOKINETICS, INCORPORATED
Patrimonio netto: 6 M $ in data 31/05/2026
Profilo
John Tannahill Henderson currently works at Cytokinetics, Inc., as Chairman from 2022.
Dr. Henderson also formerly worked at Asmacure Ltée, as Chairman, Myriad Genetics, Inc., as Independent Director in 2020, Inveresk Research Group, Inc., as Non-Executive Director, Myrexis, Inc., as Independent Director from 2011 to 2013, Pfizer Pharmaceuticals, Inc., as Vice President, Futurepharm LLC, as President, NeuroVia, Inc., as Chief Development Officer, and Pfizer Inc., as VP-Europe, US & International Pharmaceuticals.
Dr. Henderson received his undergraduate degree and doctorate degree from The University of Edinburgh.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 27/05/2026 | 78.171 ( 0,06% ) | 6 M $ | 31/05/2026 |
Posizioni attive di John Henderson
| Società | Posizione | Inizio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Presidente | 08/04/2022 |
Precedenti posizioni note di John Henderson
| Società | Posizione | Fine |
|---|---|---|
| MYRIAD GENETICS, INC. | Presidente | 23/03/2020 |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Corporate Officer/Principal | 01/10/2018 |
| MYREXIS, INC. | Direttore/Membro del Consiglio | 01/01/2013 |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/12/2000 |
| PFIZER INC. | Corporate Officer/Principal | 01/12/2000 |
Formazione di John Henderson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
48
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Inveresk Research Group, Inc.
 Inveresk Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development services | Commercial Services |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Myrexis, Inc.
 Myrexis, Inc. Financial ConglomeratesFinance Engages in identifying, evaluating and making financial investments in life sciences assets | Finance |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases | Health Technology |
Pfizer Pharmaceuticals, Inc.
Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Futurepharm LLC | |
NeuroVia, Inc.
NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Health Technology |
